The guest on this week's nationally syndicated Motley Fool Money radio show is Ron Adner, an award-winning professor and author of the new book The Wide Lens: A New Strategy for Innovation. In the past decade, major pharmaceutical companies such as Eli Lilly, Pfizer, and MannKind were in a race to be the first to market an inhalable insulin. In this audio segment, Adner details how Pfizer did everything right, only to fail on a massive scale. Adner provides shareholders of pharmaceutical companies a key insight into what those companies need if they want to succeed in creating the next blockbuster drug.
Johnson & Johnson is just one of the companies in The Motley Fool's report featuring some of the biggest and best-known brand names in global business. It's called "Secure Your Future With 11 Rock-Solid Dividend Stocks," and you can get access it to it right now at no cost. Simply click here -- it's free.
